REFERENCES
- Bartzatt R., Kasher L. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature. Physiol. Chem. Phys. Med. NMR 2002; 34: 103–117, [PUBMED], [INFOTRIEVE]
- Bladon C. Pharmaceutical Chemistry. John Wiley and Sons, West Sussex 2002; 58
- Burchenal J., Burchenal J. R., Johnston S. Chemotherapy of leukemia. III. Further studies on the effect of nitrogen mustards and related compounds on transmitted mouse leukemia. Cancer 1951; 4: 353–356, [PUBMED], [INFOTRIEVE]
- Clark D. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J. Pharm Sci. 1999; 88(8)815–821, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Conners T., Jeney A., Warwick G., Whisson M. Factors influencing the sensitivity of tumors to nitrogen mustards. Isotop. Exp. Pharmacol. 1965; 1965: 433–438
- Elderfield R., Roy J. Synthesis of potential anticancer agents. XVIII. Nitrogen mustards from 6-substituted coumarins. J. Med. Chem. 1967; 10(5)918–921, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gringauz A. Medicinal Chemistry. Wiley-VCH, New York 1997; 102–138
- Hamamoto K., Kida Y., Zhang Y., Shimizu T., Kuwano K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 2002; 46(11)741–749, [PUBMED], [INFOTRIEVE]
- Hansch C., Leo A. Explorsing QSAR. American Chemical Society, Washington, DC 1995; 394–395
- Herrero J., Valencia A., Dopazo J. A hierarchical unsupervised growing neural network for clustering gene expression patterns. Bioinformatics 2001; 17: 126–136, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Keitel R., Poege A. Testing of some nitrogen mustard compounds for cytosta-tic activity by a screening test. Archiv Fuer Geschwulstforschung. 1975; 43(2)168–171
- Kelder J., Grootenhuis P., Bayada D., Delbressine L., Ploemer J.-P. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm. Res. 1999; 16(10)1514–1519, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lipinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Drug Del. Rev. 1997; 23: 3–25, [CROSSREF]
- Mathur I., Gupta H., Gupta S. K. Antitumor activity of certain N-arylmethyl nitrogen mustards in Walker carcinosarcoma 256 and lymphocytic leukemia P 388. Ind. Vet. Med. J. 1977; 1(1)11–19
- Mattes W., Hartley J., Kohn K. DNA sequence selectivity of guanine N-7 alkylation by nitrogen mustards. Nucleic Acids Res. 1986; 14(7)2971–2987, [PUBMED], [INFOTRIEVE]
- Nogrady T. Medicinal Chemistry. Oxford University Press, New York 1988; pp. 412–417
- Palm K., Stenberg P., Luthman K., Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res. 1997; 14(5)568–571, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Peiper R., Erickson L. DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro. Carcinogenesis. 1990; 11: 1739–1746
- Popp F., Roth S., Kirby J. Synthesis of potential anticancer agents. IX. Some cycloalkyl mustards and related compounds. J. Med. Chem. 1963; 6: 83–86, [CROSSREF]
- Sampey J. Nitrogen mustards in the management of Hodgkin's disease and the leukemias. J. S. Carolina Med. Assoc. 1963; 59: 272–274
- Sela M., Zisman E. Different roles of D-amino acids in immune phenomena. FASEB J. 1997; 11: 449–456, [PUBMED], [INFOTRIEVE]
- Silverman R. The Organic Chemistry of Drug Design and Drug Action. Academic Press, San Diego, CA 1992; 244–251
- Workman P. Inhibition of human prostatic tumor acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards. Chem. Biolog. Interactions 1978; 20(1)103–112, [CROSSREF]
- Xia X., Xie Z. AMADA: analysis of microarray data. Bioinformatics 2001; 17: 569–570, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zulik R. Treatment of malignancies of the lymphoid and reticular systems by a new nitrogen mustard derivative. Arzneimittel-Forschung 1958; 8: 360–361, [PUBMED], [INFOTRIEVE]